Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm
Ontology highlight
ABSTRACT: The purpose of the study is to evaluate whether the novel anti-cancer drug OXY111A is safe and tolerated in patients with primary and secondary hepato-pancreato-biliary and gastrointestinal neoplasia as measured by exploring the maximum tolerated dose (MTD). At level of MTD, additional patients will be included aimed for assessing the efficacy profile in these neoplasia entities.
DISEASE(S): Colorectal Neoplasms,Carcinoma, Hepatocellular,Hepatocellular Cancer,Liver Neoplasms,Pancreatic Neoplasms,Cholangiocarcinoma,Neoplasms
PROVIDER: 2196481 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA